Key facts
- AstraZeneca aims to generate $80 billion in revenue by 2030.
- The company is broadening its US shareholder base.
- CFO Aradhana Sarin discussed the growth strategy.
AstraZeneca's Chief Financial Officer, Aradhana Sarin, has detailed the company's strategic initiatives to enhance its presence and revenue generation within the United States. Sarin indicated that the pharmaceutical firm is actively working to broaden its US shareholder base. Furthermore, AstraZeneca has set an ambitious target of generating $80 billion in revenue by the year 2030. This forward-looking strategy underscores the company's commitment to significant growth in the US market. The discussion was held with Bloomberg's Katie Greifeld.